Moxifloxacin Impurity 55 CAS 53764-99-1
| CAS No. | 53764-99-1 |
| Molecular Formula | C11H9F3O2 |
| Molecular Weight | 230.18 g/mol |
| Category | Pharmacopoeial Impurity Standards / EP Impurities |
| Availability | In Stock |
Chemical Structure
Description
Based on its molecular formula C11H9F3O2, Moxifloxacin Impurity 55 contains a carboxylic acid group, a hydroxyl group, an ether linkage, fluorine substitution, an aromatic ring system; these features give the compound characteristic absorption bands in UV spectroscopy. The molecular weight of 230.18 g/mol is directly relevant to the identification of the molecular ion in mass spectrometry. The high carbon-to-hydrogen ratio imparts good lipophilicity, allowing liquid-liquid extraction with non-polar solvents such as n-hexane or ethyl acetate.
Moxifloxacin Impurity 55 (CAS 53764-99-1) is a certified pharmaceutical impurity reference standard with the molecular formula C11H9F3O2 and a molecular weight of 230.18 g/mol.
This reference standard supports related-substances testing and method development in line with ICH Q3A/Q3B guidance on impurity control, and is suitable for system suitability testing and forced-degradation studies.
CATO manufactures Moxifloxacin Impurity 55 under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.
Physical & Chemical Properties
| Molecular Formula | C11H9F3O2 |
| Molecular Weight | 230.18 g/mol |
| Appearance | Off-white to pale yellow crystalline powder. (slight halide-like odor, low volatility) |
| Purity | >95% |
| Storage | Store at 2-8°C, protect from light, keep tightly closed to prevent evaporation |
| Solubility (reference) | Soluble in chloroform, dichloromethane, ethyl acetate, DMSO |
| Stability | May oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light; Contains ester bond; hydrolyzes under strong alkaline conditions |
| Degree of Unsaturation (DBE) | 6.0 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| CAS Registry Year (est.) | 1972 |
| Halogen Content | F-containing |
Related Moxifloxacin Standards
- Moxifloxacin impurity 160 (CAS 1415319-29-7)
- Moxifloxacin Impurity 95 (CAS 71083-22-2)
- Moxifloxacin Impurity N43 (CAS 1263376-71-1)
- Moxifloxacin Impurity 16 (CAS 28749-88-4)
- Moxifloxacin Impurity N39 (CAS 1824286-08-9)
- Moxifloxacin Impurity 70 (CAS 133492-64-5)
- Moxifloxacin Impurity 114 (CAS 652-03-9)
- Moxifloxacin Impurity 64 (CAS 18184-75-3)
Recommended Standards
- Cinacalcet Impurity 96 (CAS CATO-C4X-105996)
- 2-(Methylamino)-2-(4-(trifluoromethoxy)phenyl)acetonitrile (CAS 1039814-37-3)
- Celecoxib Impurity 67 (CAS 910303-54-7)
- 1,4-Dioxo-1,3a,4,5-tetrahydropentalen-3a-yl hydrogen sulfate (CAS 108347-23-5)
- Sorafenib Impurity 51 (CAS 52943-20-1)
- Loratadine EP Impurity 39 (CAS 609806-38-4)
- Bempedoic Acid Impurity N4 (CAS 119703-02-5)
- 3,4-Diisobutoxyaniline (CAS 39051-98-4)
- 1-[4-(1h-pyrazol-1-yl)phenyl]ethan-1-ol (CAS 956806-16-9)
- 2-{[4-(morpholin-4-yl)-1,2,5-thiadiazol-3-yl]oxy}acetic acid (CAS 66950-03-6)
- 3-Chloro-N-(3-iodophenyl)benzamide (CAS 897752-37-3)
- 3-Iodo-o-xylene (CAS 31599-60-7)
- 2-(Difluoromethyl)-1,3,4-trifluorobenzene (CAS 1214326-80-3)
- Palmitoyl Tripeptide-8 TFA salt (CAS 936544-53-5)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 18665070610 / Nicole.chen@cato-chem.com